According to a statement by Alchemia Ltd, an Australian pharmaceutical company which has marketing tie up with the city-based drug maker.

Dr Reddy's Laboratories is set to take its limited-competition drug fondaparinux sodium to the European market.

Dr Reddy's Labs has resolved all issues raised by a division of US health regulator over its promotional material for an anti-coagulant inj...

Dr Reddy's Labs has run into trouble with the US health authorities again, this time for not highlighting important risk information on a p...

Dr Reddy's Lab yesterday reported its quarterly results with a 20 pc uptick in profits however shares continued its southward journet today...

DRL has received the final approval from USFDA to launch Fondaparinux Sodium injection, used for treating deep vein thrombosis (DVT).

DRL and Brisbane-based Alchemia Limited today announced that the USFDA has given approval for Fondaparinux Sodium injection.

Indian Pharma major Dr Reddy Laboratories signed an agreement with Alchemia, an Australian Pharmaceutical company, for marketing Fondaparin...

Arcelor Mittal has decided to sell off a steel unit in Poland. The sale of Huta Bankowa to Alchemia Capital group is the third such sale of...